// startup autopsy
Norak Biosciences
Receptor science without a cure for cash burn
marketfitSilent Shutdown
Quiet closure with no public announcement · Fatal mistake: Norak failed to establish pharma licensing deals before its $13M runway expired, leaving it without a commercial anchor.
Key Events Timeline
FOUNDING
Norak Biosciences founded in the USA to pursue receptor biology drug discovery research.
FUNDING
Raised approximately $13M across early funding rounds to fuel receptor biology research programs.
PRODUCT LAUNCH
Last funding activity recorded; no licensing deals or drug candidates advanced to clinical stage.
SHUTDOWN
Norak Biosciences quietly ceased operations after exhausting capital with no commercial product or acquisition outcome.